Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Minimally Invasive Colon Cancer Surgery Found Effective

By HospiMedica staff writers
Posted on 25 May 2004
A study by an international team of surgeons has determined that minimally invasive surgery is as safe and effective as standard open surgery for most patients with cancer confined to the colon. More...
The results were reported in the May 13, 2004, issue of The New England Journal of Medicine.

In addition to the cosmetic benefits of having a smaller incision, patients who received the minimally invasive procedure, called laparoscopically assisted colectomy, required one less day in the hospital, one less day on intravenous pain killers, and one less day on oral pain killers. Typically, surgeons open the abdomen with a six-to-eight-inch incision and then cut away the portion of the colon containing cancer. During laparoscopically assisted colectomy, the same procedure is performed through three one-half-inch incisions and one two-inch incision.

During their investigation, the team of surgeons put a moratorium on laparoscopically assisted colectomy performed outside the scope of their study. They also enforced qualifications requirements for the 66 surgeons who participated in the study, and established standardized operating procedures. The results showed that cancer returned to the colon or to the location of the surgical wound at almost the exact same rate in both groups of patients. The survival rates, overall survival, and rates of complications also were nearly identical.

The research team has submitted a position statement to the American Society of Colon and Rectal Surgeons proposing that credentials for performing laparoscopically assisted colectomies should only be given to surgeons who meet specific qualifications and strictly adhere to standard operating procedures. "Our plea is that the surgical community apply the same standard operating techniques known to safely remove cancer when they perform this less-invasive procedure,” said James W. Fleshman Jr., M.D., professor of surgery at Washington University School of Medicine in St. Louis (MO, USA) and a key contributor to the study, led by the Mayo Clinic (Rochester, MN, USA).




Related Links:
Washington U. School of Med.

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.